Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04635228 · ClinicalTrials.gov registry record
Biodesign® Otologic Repair Graft
A clinical trial, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- 87
- Enrollment target
NCT04635228: Completed study, sponsored by Cook Research Incorporated.
NCT04635228 is a clinical trial that has completed, run by Cook Research Incorporated. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04635228 has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The post-market follow-up clinical trial of the Cook® Biodesign® Otologic Repair Graft will follow patients up to 3 months post-implantation to determine the percent of patients with complete closure of the tympanic membrane.
Primary Outcome
Percent of patients with complete closure of the tympanic membrane.
Interventions
- DEVICE Biodesign Otologic Repair Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2025-12-23 |
What the finished NCT04635228 record still lists
NCT04635228 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Biodesign Otologic Repair Graft is the first listed.
NCT04635228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04635228 about?
NCT04635228 is a clinical study titled "Biodesign® Otologic Repair Graft". The post-market follow-up clinical trial of the Cook® Biodesign® Otologic Repair Graft will follow patients up to 3 months post-implantation to determine the percent of patients with complete closure of the tympanic membrane.
What is the current status of trial NCT04635228?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2021-09-29. Estimated completion is 2025-12-23.
What interventions are being tested in trial NCT04635228?
The interventions under investigation include: Biodesign Otologic Repair Graft (DEVICE).
Who is sponsoring clinical trial NCT04635228?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI